ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE: 600479)
Health Care · Pharmaceuticals · CN
CN¥12.44
+0.32% today · +18.7% 1Y
ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE: 600479) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $914.15M and employs 5,041 people.
Over the last twelve months the share price has gained 18.7%, trading between 9.20 and 15.25.
Tweenvest scores ZhuZhou QianJin Pharmaceutical Co.,Ltd across four factors: quality 82/100, value 20/100, growth 37/100, dividend 98/100. Its strongest factor is dividend.
600479 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $914.15M
- Revenue (TTM)
- $548.98M
- P/E
- 17.04
- EPS
- 0.73
- Dividend yield
- 2.89%
- Beta (5Y)
- 0.25
- 52-week high
- CN¥15.25
- 52-week low
- CN¥9.20
- Avg volume (3M)
- —
- Shares outstanding
- 492.21M
- Employees
- 5,041
- Next earnings
- —
About ZhuZhou QianJin Pharmaceutical Co.,Ltd
Established in 1993 and headquartered in Zhuzhou, China, ZhuZhou QianJin Pharmaceutical Co.,Ltd operates as a leading manufacturer and distributor of pharmaceutical goods throughout China. The company boasts a comprehensive product portfolio, encompassing treatments for women's health, pediatric ailments, dermatological concerns, anti-infectives, and conditions affecting the circulatory, endocrine, digestive, nervous, and cardiovascular systems. Additionally, they offer specialized medications and traditional Chinese remedies. These diverse pharmaceutical offerings are presented in various formats, including pills, tablets, capsules, granules, powders, decoctions, and liquid solutions. Beyond its core pharmaceutical business, ZhuZhou QianJin also produces ginger-based beverages, feminine hygiene products, and alcoholic beverages.
- ISIN
- CNE000001GX3
- Founded
- 1966
- Listed since
- Mar 12, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KPC Pharmaceuticals,Inc.SHSE: 600422 | $944.79M | CN¥8.36 | +3.08% |
| Guizhou Bailing Group Pharmaceutical Co., Ltd.SZSE: 002424 | $939.47M | CN¥4.61 | -1.71% |
| Daewoong Pharmaceutical Co., LtdKOSE: A069620 | $928.63M | ₩108,500.00 | -0.46% |
| Alumis Inc.NasdaqGS: ALMS | $926.76M | $7.17 | +0.14% |
| Hainan Haiyao Co., Ltd.SZSE: 000566 | $912.29M | CN¥4.71 | +1.95% |
| Bide Pharmatech Co., Ltd.SHSE: 688073 | $906.79M | CN¥70.50 | -7.96% |
| Procter & Gamble Health LimitedBSE: 500126 | $894.55M | Rs5,215.55 | +1.12% |
| Youcare Pharmaceutical Group Co., Ltd.SHSE: 688658 | $887.89M | CN¥13.38 | -4.70% |
Figures last refreshed Oct 11, 2026.